solifenacin succinate

A muscarinic receptor antagonist drug used for treating contraction of overactive bladder such as incontinence, urinary frequency, and urgency. Solifenacin is a competitive cholinergic receptor antagonist, selective for the M3 receptor subtype. It was manufactured and marketed by Astellas, GlaxoSmithKline and Teva Pharmaceutical Industries.[ Reference standards of Solifenacin Succinate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

No Data Found